Principal Scientist

Dr. Vora is a Principal Scientist at New Iridium focusing on the application of photoredox technology to solving problems in the chemical industry. He received is B Sc. at the University of Pittsburgh ( Prof. Paul Floreancig) and pursued his doctoral studies at Colorado State University (Prof. Tom Rovis). He conducted his post doctoral work at The Scripps Research Institute ( Prof. Jin-Quan Yu) where his work focused on C-H activation. Additionally, he provides the company with experience from the pharmaceutical sector ( Roche & Merck) and the biotech arena ( C4 Therapeutics & Casma Therapeutics) where the bulk of his attention spanned the medicinal chemistry space.